Evoke Pharma Inc - Common Stock, par value $0.0001 per share (EVOK)

CUSIP: 30049G302

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
1,552,381
Total 13F shares
242,206
Share change
+23,750
Total reported value
$666,068
Price per share
$2.75
Number of holders
9
Value change
+$63,212
Number of buys
3
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 30049G302?
CUSIP 30049G302 identifies EVOK - Evoke Pharma Inc - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Evoke Pharma Inc - Common Stock, par value $0.0001 per share (EVOK) as of Q1 2025

As of 31 Mar 2025, Evoke Pharma Inc - Common Stock, par value $0.0001 per share (EVOK) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 242,206 shares. The largest 9 holders included Nantahala Capital Management, LLC, Bleichroeder LP, CITADEL ADVISORS LLC, Tower Research Capital LLC (TRC), BlackRock, Inc., SBI Securities Co., Ltd., MORGAN STANLEY, NewEdge Advisors, LLC, and BANK OF AMERICA CORP /DE/. This page lists 9 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.